Both in Pharmaceuticals
Sagimet Biosciences Inc. Series A vs Wave Life Sciences
Over the past year SGMT returned +23.0% and WVE returned −55.7%; their daily moves had a correlation of 0.04.
SGMT +23.0% WVE −55.7%Growth of $1, one year, split-adjusted
| Metric | SGMT | WVE |
|---|---|---|
| Price | $9.95 | $3.58 |
| Market cap | $705.5M | $706.1M |
| Today | +2.68% | +1.70% |
| 1 month | +10.2% | −4.5% |
| 6 months | +28.9% | −50.1% |
| Year to date | +68.1% | −78.9% |
| 1 year | +16.8% | −60.4% |
| Revenue growth (YoY) | — | +72.9% |
| Gross margin | — | 100.0% |
| Net margin | — | −470.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 10.0× |
| Net cash | $240.1M | $430.7M |
| Dividend yield | — | — |
| Volatility (60d) | 73.1% | 62.9% |
| Short % of float | 18.7% | 17.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).